View Article

  • Development and Validation of Reverse Phase High Performance Liquid Chromatography Method for Estimation of Dapagliflozin in Bulk and Formulation

  • Pharmaceutical Technology Division, Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad-431001, Maharashtra, India

Abstract

A new, simple, rapid, accurate and precise high-performance thin layer chromatography (HPLC) method has been developed and validated according to the guidelines of the International Conference on Harmonization (ICH Q2(R1) for the estimation of dapagliflozin in bulk and formulation. The chromatographic analysis was performed by an Agilent HPLC instrument using a BDS Hypersil, C-18, 250mmx4.6mm, 5 ?m and mobile phase comprising 0.1% ortho-phosphoric acid in water and acetonitrile (65:35 v/v) at flow rate of 1.0 ml/min. The eluent was monitored at 225 nm for determination of dapagliflozin. The total run time was 10 min and the average retention time of Dapagliflozin was found to be 5.31 min. The calibration curves were linear over the range of 1-20 ng/mL (R2 = 0.999). The intra- and inter-day accuracy and precision values for all the analytes were within the acceptable range. The LOD and LOQ were 0.2076 and 0.9628 ng/mL. The developed method was found to be robust. A simple, precise, accurate, linear and rapid RP-HPLC method was developed and validated as per ICH guidelines. The results suggest that the developed method was found to be robust and it can be applicable in routine analysis and efficiently used for the estimation of dapagliflozin in bulk as well as combined dosage form.

Keywords

Dapagliflozin, HPLC method development, Validation

Reference

  1. Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M, Wang B, Deng Y, Cai J, Couerbe P, Arnold M. Validated LC-MS/MS methods for the determination of dapagliflozin, a sodium-glucose cotransporter 2 inhibitor in normal and ZDF rat plasma. Bioanalysis 2010; 2(12):2001-2.
  2. James List F. MD. PhD, Vincent Woo. MD, Enrique Morales. MD, Weihua Tang. PhD, Fred T. Fiedorek. MD. Sodium-glucose co-transport inhibition with Dapagliflozin in type 2 diabetes. Diabetes care 2009; 32(4):650-657.
  3. Lambers Heerspink H. J, De Zeeuw D, Wie L, Leslie B, List J. Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes, Obesity and Metabolism. 2013; 15:853- 862.
  4. Timothy Reilly P, Michael Graziano J, Evan Janovitz B, Thomas Dorr E, Craig Fairchild, Francis Lee, Jian Chen, Tai Wong, Jean Whaley M, Mark Tirmenstein. Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus. Diabetes Ther. 2014.
  5. John Wiley & Sons Ltd. Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice. Diabetes, Obesity and Metabolism. 2014; 16:376-380.
  6. Yunoos M and Sankar G: A validated stability indicating high-performance liquid chromatographic method for simultaneous determination of metformin HCl and Dapagliflozin in bulk drug and tablet dosage form. Asian Journal of Pharmaceutical and Clinical Research 2015; 8(3).
  7. Urooj A and Sundar PS: Development of a new stability indicating RP-HPLC method for simultaneous estimation of Dapagliflozin and metformin in bulk and synthetic mixture. World Journal of Pharmacy and Pharmaceutical Sciences 6(7): 2139-2150.
  8. Suma BDR and Shenoy P: A new high performance thin layer chromatographic method development and validation of Dapagliflozin in bulk and tablet dosage form. International Journal of Pharmacy and Pharmaceutical Sciences 2019; 11(8): 58-63.
  9. Note for guidance on validation of analytical procedures: text and methodology. European Medicines Agency: 1995; 1-15.
  10. Validation of analytical procedures: text and methodology q2 (r1). ICH harmonised tripartite guideline, (1994).

Photo
Sachin Bhusari
Corresponding author

Pharmaceutical Technology Division, Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad-431001, Maharashtra, India

Photo
Pritesh Jawale
Co-author

Pharmaceutical Technology Division, Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad-431001, Maharashtra, India

Photo
Pravin Wakte
Co-author

Pharmaceutical Technology Division, Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad-431001, Maharashtra, India

Sachin Bhusari*, Pritesh Jawale, Pravin Wakte, Development and Validation of Reverse-Phase High-Performance Liquid Chromatography Method for Estimation of Dapagliflozin in Bulk and Formulation, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 10, 78-84. https://doi.org/10.5281/zenodo.8428473

More related articles
Photoredox-Catalyzed C-H Amination: Recent Advance...
Haval Chauhan, Ajaysinh Vaghela, ...
Format for Standard Protocols...
Javed Ali Khan, Pathan Jamal Khan, Anwar Ahmed, ...
Roll of Pharmacogenomics in Personalized Medicine...
Srushti Dalve, Venkatesh Nagare , Dr. Swati P. Deshmukh, ...
Related Articles
Mouth Dissolving Films for Oral Drug Delivery: A Review...
Sayali Bedare, Dr. Sachin Hangargekar, Amruta Magar, Vikas Bhosale, Gangaram Kartale, ...
Optimization And Validation of RP HPLC Method for The Quantification of Betaxolo...
Sk Ashpak Sk Harun, Aejaz Ahmed Abdul Rafique, Gulam Javed Khan, Shakeer Ahmad Shayaque Ahmad, ...
Stability Indicating Rp-HPLC Method Development And Validation For The Estimatio...
Trupti Bhalekar, Kalpana Sable, Jaya Mehetre, Kiran Dhamak , ...
More related articles
Format for Standard Protocols...
Javed Ali Khan, Pathan Jamal Khan, Anwar Ahmed, ...
Roll of Pharmacogenomics in Personalized Medicine...
Srushti Dalve, Venkatesh Nagare , Dr. Swati P. Deshmukh, ...
Format for Standard Protocols...
Javed Ali Khan, Pathan Jamal Khan, Anwar Ahmed, ...
Roll of Pharmacogenomics in Personalized Medicine...
Srushti Dalve, Venkatesh Nagare , Dr. Swati P. Deshmukh, ...